secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001437749-24-019834
Event type: other
Sentiment:  positive
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics shareholders approve all proposals at 2024 annual meeting
----------------------------------------------------------------------

- All five director nominees elected: Scott Davis, Mary Ann Cloyd, Corinna Lathan, Charles Li, Deborah Lafer Scher.
- Equity incentive plan extended to April 2034; authorized shares increased to 4,724,286 (1M increase).
- Advisory say-on-pay approved: 6,303,399 for, 631,663 against, 124,065 abstained.
- Annual frequency for future advisory votes selected: 6,840,255 for 1 year.
- WithumSmith+Brown ratified as auditor for FY2024: 11,245,624 for, 153,991 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924019834/0001437749-24-019834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924019834/ekso20240610_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-019834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer